OPEN ACCESS: All - Edward Davies
- 1New York
Ranbaxy Pharmaceuticals has stopped production and issued a recall of its generic version of the cholesterol lowering drug atorvastatin.
The recall applies to certain lots of the company’s 10 mg, 20 mg, and 40 mg tablets. The lots of atorvastatin, packaged in bottles of 90 and 500 tablets, are being …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
PDF
Social bookmarking